Literature DB >> 19303366

Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children.

Theodore Ruel1, Isaac Ssewanyana, Jane Achan, Anne Gasasira, Moses R Kamya, Adeodata Kekitiinwa, Joseph K Wong, Huyen Cao, Diane Havlir, Edwin D Charlebois.   

Abstract

Africans have elevated T cell activation compared to residents of Europe or the USA. Levels of T cell activation also correlate with disease progression in HIV-infected individuals. We sought to determine if treatment with antiretroviral therapy (ART) would reduce levels of T cell activation (CD38 and HLADR co-expression) in HIV-infected Ugandan children. The median CD8+ T cell activation level among 199 ART-treated children (30%) was lower than in 57 ART-naïve children (45%, p<0.001), but remained higher than in 30 HIV-uninfected children (18%, p<0.001). Among ART-treated children, CD4% was inversely correlated with both CD8- (rho=-0.61, p<0.001) and CD8+ (rho=-0.38, p<0.001) T cell activation. Prospectively, CD4 recovery correlated with post-treatment CD8+ T cell activation level (p=0.008). Our data suggest that significant decreases in T cell activation accompany CD4 recovery in ART-treated HIV-infected African children, to levels that approach but do not reach those of uninfected children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19303366      PMCID: PMC3032795          DOI: 10.1016/j.clim.2009.01.016

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  20 in total

1.  Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy.

Authors:  Chris A R Baker; Nneka Emenyonu; Isaac Ssewanyana; Norman G Jones; Mohamed Elrefaei; Frehd Nghania; Justine Nakiwala; Irene Andia; Richard Clark; Jeffrey Martin; David R Bangsberg; Huyen Cao
Journal:  AIDS Res Hum Retroviruses       Date:  2007-07       Impact factor: 2.205

2.  CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy.

Authors:  Salvador Resino; Elena Seoane; Maria Dolores Gurbindo Gutiérrez; Juan Antonio León; Maria Angeles Muñoz-Fernández
Journal:  J Acquir Immune Defic Syndr       Date:  2006-07       Impact factor: 3.731

3.  Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection.

Authors:  Howard M Rosenblatt; Kenneth E Stanley; Lin Y Song; George M Johnson; Andrew A Wiznia; Sharon A Nachman; Paul A Krogstad
Journal:  J Infect Dis       Date:  2005-06-29       Impact factor: 5.226

4.  Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire.

Authors:  P Ondoa; S Koblavi-Dème; M-Y Borget; M L Nolan; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

5.  Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy.

Authors:  Mary E Paul; Charlotte Mao; Manhattan Charurat; Leslie Serchuck; Marc Foca; Karen Hayani; Edward L Handelsman; Clemente Diaz; Kenneth McIntosh; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2005-04       Impact factor: 10.793

6.  T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.

Authors:  Mark P Eggena; Banson Barugahare; Martin Okello; Steven Mutyala; Norman Jones; Yifei Ma; Cissy Kityo; Peter Mugyenyi; Huyen Cao
Journal:  J Infect Dis       Date:  2005-01-31       Impact factor: 5.226

7.  Profile of T cell immune responses in HIV-infected children from Uganda.

Authors:  Isaac Ssewanyana; Mohamed Elrefaei; Grant Dorsey; Theodore Ruel; Norman G Jones; Anne Gasasira; Moses Kamya; Justine Nakiwala; Jane Achan; Edwin Charlebois; Diane Havlir; Huyen Cao
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

8.  Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children.

Authors:  Moses R Kamya; Anne F Gasasira; Jane Achan; Tsedal Mebrahtu; Theodore Ruel; Adeodata Kekitiinwa; Edwin D Charlebois; Philip J Rosenthal; Diane Havlir; Grant Dorsey
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

9.  Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.

Authors:  Grant Dorsey; Sarah Staedke; Tamara D Clark; Denise Njama-Meya; Bridget Nzarubara; Catherine Maiteki-Sebuguzi; Christian Dokomajilar; Moses R Kamya; Philip J Rosenthal
Journal:  JAMA       Date:  2007-05-23       Impact factor: 56.272

10.  T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping.

Authors:  S Plaeger-Marshall; V Isacescu; S O'Rourke; J Bertolli; Y J Bryson; E R Stiehm
Journal:  Clin Immunol Immunopathol       Date:  1994-04
View more
  6 in total

1.  Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.

Authors:  Peter W Hunt; Huyen L Cao; Conrad Muzoora; Isaac Ssewanyana; John Bennett; Nneka Emenyonu; Annet Kembabazi; Torsten B Neilands; David R Bangsberg; Steven G Deeks; Jeffrey N Martin
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

2.  Recent Thymus Emigrant CD4+ T Cells Predict HIV Disease Progression in Patients With Perinatally Acquired HIV.

Authors:  Ramia Zakhour; Dat Q Tran; Guenet Degaffe; Cynthia S Bell; Elizabeth Donnachie; Weihe Zhang; Norma Pérez; Laura J Benjamins; Gabriela Del Bianco; Gilhen Rodriguez; James R Murphy; Gloria P Heresi
Journal:  Clin Infect Dis       Date:  2016-02-21       Impact factor: 9.079

3.  Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy.

Authors:  Edwin D Charlebois; Theodore D Ruel; Anne F Gasasira; Jane Achan; Frederick Kateera; Caroline Akello; Huyen Cao; Grant Dorsey; Philip J Rosenthal; Isaac Ssewanyana; Moses R Kamya; Diane V Havlir
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

4.  Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Authors:  Dwight E Yin; Meredith G Warshaw; William C Miller; Hannah Castro; Susan A Fiscus; Lynda M Harper; Linda J Harrison; Nigel J Klein; Joanna Lewis; Ann J Melvin; Gareth Tudor-Williams; Ross E McKinney
Journal:  Pediatrics       Date:  2014-10       Impact factor: 7.124

5.  Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.

Authors:  Kaitlin Rainwater-Lovett; Hope Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn B Moore; Joseph Margolick; William J Moss
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

6.  Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset.

Authors:  Livio Azzoni; Russell Barbour; Emmanouil Papasavvas; Deborah K Glencross; Wendy S Stevens; Mark F Cotton; Avy Violari; Luis J Montaner
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.